BMC Cancer

official impact factor 3.15

Open Access Highly Access

An integrative multi-platform analysis for discovering biomarkers of osteosarcoma

Guodong Li, Wenjuan Zhang, Huazong Zeng*, Lei Chen, Wenjing Wang, Jilong Liu, Zhiyu Zhang and Zhengdong Cai*

BMC Cancer 2009, 9:150 doi:10.1186/1471-2407-9-150

Accesses  

  • Last 30 days: 49 accesses
  • Last 365 days: 530 accesses
  • All time: 2619 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines

Zhiyu Zhang, Lijun Zhang, Yingqi Hua, Xiaofang Jia, Jian Li, Shuo Hu, Xia Peng, Pengyuan Yang, Mengxiong Sun, Fang Ma, Zhengdong Cai BMC Cancer 2010, 10:206 (14 May 2010)

Review   Open Access

Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma

Johann Micallef, Moyez Dharsee, Jian Chen, Suzanne Ackloo, Ken Evans, Luqui Qiu, Hong Chang Journal of Hematology & Oncology 2010, 3:13 (7 April 2010)